Dynamic Technology Lab Private LTD Arcus Biosciences, Inc. Transaction History
Dynamic Technology Lab Private LTD
- $914 Million
- Q3 2024
A detailed history of Dynamic Technology Lab Private LTD transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 35,053 shares of RCUS stock, worth $491,793. This represents 0.06% of its overall portfolio holdings.
Number of Shares
35,053
Previous 17,722
97.79%
Holding current value
$491,793
Previous $270,000
98.15%
% of portfolio
0.06%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding RCUS
# of Institutions
200Shares Held
51.5MCall Options Held
236KPut Options Held
141K-
Black Rock Inc. New York, NY9.76MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$76.7 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.48MShares$48.8 Million0.48% of portfolio
-
State Street Corp Boston, MA3.01MShares$42.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.44MShares$34.2 Million0.1% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.01B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...